Siga Technologies Shares Outstanding 2006-2019 | SIGA

Siga Technologies shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Siga Technologies Annual Shares Outstanding
(Millions of Shares)
2018 83
2017 79
2016 57
2015 54
2014 53
2013 52
2012 52
2011 54
2010 45
2009 37
2008 35
2007 33
2006 28
2005 25
Siga Technologies Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 82
Q4 2018 83
Q3 2018 83
Q2 2018 79
Q1 2018 79
Q4 2017 79
Q3 2017 79
Q2 2017 79
Q1 2017 79
Q4 2016 57
Q3 2016 54
Q2 2016 54
Q1 2016 54
Q4 2015 54
Q3 2015 54
Q2 2015 54
Q1 2015 54
Q4 2014 53
Q3 2014 54
Q2 2014 53
Q1 2014 53
Q4 2013 52
Q3 2013 53
Q2 2013 52
Q1 2013 52
Q4 2012 52
Q3 2012 52
Q2 2012 52
Q1 2012 52
Q4 2011 54
Q3 2011 52
Q2 2011 55
Q1 2011 50
Q4 2010 45
Q3 2010 46
Q2 2010 44
Q1 2010 43
Q4 2009 37
Q3 2009 38
Q2 2009 37
Q1 2009 36
Q4 2008 35
Q3 2008 35
Q2 2008 35
Q1 2008 34
Q4 2007 33
Q3 2007 34
Q2 2007 41
Q1 2007 33
Q4 2006 28
Q3 2006 28
Q2 2006 27
Q1 2006 27
Q4 2005 25
Q3 2005 25
Q2 2005 25
Q1 2005 25
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.443B $0.477B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.030B 33.88
Takeda Pharmaceutical (TAK) Japan $26.701B 7.84
Grifols (GRFS) Spain $13.249B 16.76
Sage Therapeutics (SAGE) United States $8.913B 0.00
Ionis Pharmaceuticals (IONS) United States $8.713B 19.05
Neurocrine Biosciences (NBIX) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.390B 10.13
Catalent (CTLT) United States $7.241B 29.06
Nektar Therapeutics (NKTR) United States $5.822B 9.49
Tilray (TLRY) Canada $3.793B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.518B 12.34
FibroGen (FGEN) United States $3.505B 0.00
United Therapeutics (UTHR) United States $3.427B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.448B 368.86
PTC Therapeutics (PTCT) United States $2.338B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.052B 7.39
Pacira Pharmaceuticals (PCRX) United States $1.803B 87.32
Xencor (XNCR) United States $1.764B 48.17
Portola Pharmaceuticals (PTLA) United States $1.754B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Tricida (TCDA) United States $1.694B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.688B 23.07
Zogenix (ZGNX) United States $1.661B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.604B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.504B 0.00
Aerie Pharmaceuticals (AERI) United States $1.457B 0.00
Heron Therapeutics (HRTX) United States $1.398B 0.00
Esperion Therapeutics (ESPR) United States $1.324B 0.00
Turning Point Therapeutics (TPTX) United States $1.245B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
Radius Health (RDUS) United States $1.014B 0.00
Endo (ENDP) Ireland $0.916B 1.47
ArQule (ARQL) United States $0.896B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.895B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.834B 0.00
CannTrust Holdings (CTST) Canada $0.683B 0.00
Organogenesis Holdings (ORGO) United States $0.669B 0.00
Odonate Therapeutics (ODT) United States $0.669B 0.00
Aptorum Group (APM) China $0.649B 0.00
TherapeuticsMD (TXMD) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.562B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.521B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Dermira (DERM) United States $0.506B 0.00
ChemoCentryx (CCXI) United States $0.484B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
GlycoMimetics (GLYC) United States $0.483B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Flexion Therapeutics (FLXN) United States $0.414B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 20.65
Collegium Pharmaceutical (COLL) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.391B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.374B 0.00
Karyopharm Therapeutics (KPTI) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 0.00
KalVista Pharmaceuticals (KALV) United States $0.343B 0.00
Forty Seven (FTSV) United States $0.331B 0.00
TCR2 Therapeutics (TCRR) United States $0.327B 0.00
Rafael Holdings (RFL) United States $0.306B 0.00
CASI Pharmaceuticals (CASI) United States $0.301B 0.00
ImmunoGen (IMGN) United States $0.296B 0.00
Harpoon Therapeutics (HARP) United States $0.290B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
OptiNose (OPTN) United States $0.285B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.263B 0.00
Molecular Templates (MTEM) United States $0.262B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Concert Pharmaceuticals (CNCE) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.240B 0.00
Aratana Therapeutics (PETX) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.205B 1.99
Calithera Biosciences (CALA) United States $0.204B 0.00
Recro Pharma (REPH) United States $0.201B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
IMV INC (IMV) Canada $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 57.31
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
MEI Pharma (MEIP) United States $0.175B 0.00
Minerva Neurosciences (NERV) United States $0.172B 0.00
Galectin Therapeutics (GALT) United States $0.168B 0.00
Ardelyx (ARDX) United States $0.167B 0.00
Opexa Therapeutics (ACER) United States $0.166B 0.00
Bio Blast Pharma (ENLV) Israel $0.164B 0.00
Redhill Biopharma (RDHL) Israel $0.158B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.146B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Majesco Entertainment (PTE) United States $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.119B 0.00
Tyme Technologies (TYME) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.114B 0.00
AgeX Therapeutics (AGE) United States $0.111B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Champions Oncology (CSBR) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 69.44
Natural Alternatives (NAII) United States $0.092B 9.15
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.089B 0.00
Mast Therapeutics (SVRA) United States $0.088B 0.00
Cardiome Pharma (CORV) Canada $0.088B 0.00
Capnia (SLNO) United States $0.087B 0.00
DURECT (DRRX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.074B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.051B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
Lipocine (LPCN) United States $0.040B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.037B 0.00
PharmAthene (ALT) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
IsoRay (ISR) United States $0.030B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.027B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.38
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.82
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00